AbbVie Inc. is a leading global biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of innovative pharmaceuticals. Established as a spin-off from Abbott ... AbbVie Inc. is a leading global biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of innovative pharmaceuticals. Established as a spin-off from Abbott Laboratories in 2013, AbbVie focuses primarily on advanced therapies in immunology, oncology, neuroscience, and virology. Its product portfolio includes notable drugs such as Humira for autoimmune diseases, Skyrizi and Rinvoq for psoriasis and arthritis, as well as oncology treatments like Imbruvica and Venclexta. The company has expanded its pipeline and therapeutic reach through strategic acquisitions, including Allergan, which added aesthetic products like Botox, and more recent acquisitions in neuroscience and oncology. AbbVie plays a significant role in the healthcare sector by providing treatments addressing complex and chronic conditions, with a strong emphasis on innovation and broad market impact.Show lessShow more

Disclosures ESG Data Financial Data

GHG Emissions Climate Targets EU Taxonomy Energy Waste Management

Data not available

AbbVie is not subject to EU Taxonomy reporting

Based on current regulatory requirements, AbbVie is not required to report EU Taxonomy data under the CSRD framework. As a result, we have not conducted a detailed EU Taxonomy data review for this company.

If you believe this assessment should be revisited, you may submit a data coverage request and our team will review the company's regulatory applicability.

Would you like us to review AbbVie's data?

Create a free Tracenable account to signal interest in having our team review data for AbbVie.

Legal Center Contact Us